115.02
115.02 (0%)
As of Feb 14, 2025
Neurocrine Biosciences Inc [NBIX]
Source:
Company Overview
Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs, but few options.
| Country | United States |
| Headquarters | san diego, california |
| Phone Number | (858) 617-7600 |
| Industry | manufacturing |
| CEO | Neurocrine Biosciences Inc |
| Website | www.neurocrine.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $2,355.3 |
| Operating Profit | $570.5 |
| Net Income | $341.3 |
| Net Cash | $-18.1 |
Profit Ratios
| Gross Margin | $2,321.3 |
| Operating Margin | 24.2 |
| Profit as % of Revenues | 680.1% |
| Profit as % of Assets | 9.8% |
| Profit as % of Stockholder Equity | 13.2% |
Management Effectiveness
| Return on Equity | 13.2% |
| Return on Assets | 9.2% |
| Turnover Ratio | 67.6% |
| EBITA | $570.5 |
Balance Sheet and Cash Flow Measures
| Total Assets | $3,718.7 |
| Total Liabilities | $1,129 |
| Operating Cash Flow | $595.4 |
| Investing Cash Flow | $-126.8 |
| Financing Cash Flow | $-486.7 |
